Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Seminars in Oncology
|
January 19, 2019
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155)
Mario Caccese, Fililppo Ceccato, Matteo Fassan, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
Mitotane-Induced Hypothyroidism and Dyslipidemia in Adrenocortical Carcinoma: Sex Differences and Novel Evidence from a Thyroid Cell Model
Irene Tizianel, Arianna Beber, Alberto Madinelli, et al.
Neuro-Oncology Advances
|
June 7, 2024
Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a <i>GOPC::ROS1</i> fusion
Giulia Cerretti, Marta Padovan, Angela Guerriero, et al.
Journal of Thoracic Disease
|
June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?
Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.
Cancers
|
October 21, 2020
Clinical Management of Diffuse Low-Grade Gliomas
Giuseppe Lombardi, Valeria Barresi, Antonella Castellano, et al.
Journal of Endocrinological Investigation
|
October 9, 2024
Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma
Filippo Crimì, Francesca Turatto, Carlo D'Alessandro, et al.
The Oncologist
|
December 4, 2023
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities
Marta Maccari, Chooyoung Baek, Mario Caccese, et al.
Therapeutic Advances in Medical Oncology
|
June 20, 2020
Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2023
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis
Marta Padovan, Marta Maccari, Alberto Bosio, et al.
Cancers
|
March 10, 2022
Innovating Strategies and Tailored Approaches in Neuro-Oncology
Alberto Picca, David Guyon, Orazio Santo Santonocito, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Seminars in Oncology
|
January 19, 2019
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155)
Mario Caccese, Fililppo Ceccato, Matteo Fassan, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
Mitotane-Induced Hypothyroidism and Dyslipidemia in Adrenocortical Carcinoma: Sex Differences and Novel Evidence from a Thyroid Cell Model
Irene Tizianel, Arianna Beber, Alberto Madinelli, et al.
Neuro-Oncology Advances
|
June 7, 2024
Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a <i>GOPC::ROS1</i> fusion
Giulia Cerretti, Marta Padovan, Angela Guerriero, et al.
Journal of Thoracic Disease
|
June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?
Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.
Cancers
|
October 21, 2020
Clinical Management of Diffuse Low-Grade Gliomas
Giuseppe Lombardi, Valeria Barresi, Antonella Castellano, et al.
Journal of Endocrinological Investigation
|
October 9, 2024
Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma
Filippo Crimì, Francesca Turatto, Carlo D'Alessandro, et al.
The Oncologist
|
December 4, 2023
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities
Marta Maccari, Chooyoung Baek, Mario Caccese, et al.
Therapeutic Advances in Medical Oncology
|
June 20, 2020
Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2023
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis
Marta Padovan, Marta Maccari, Alberto Bosio, et al.
Cancers
|
March 10, 2022
Innovating Strategies and Tailored Approaches in Neuro-Oncology
Alberto Picca, David Guyon, Orazio Santo Santonocito, et al.
Page
of 6